|
|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
1.000
|
|
|
|
menstrual cycle phase
|
GO:0022601 |
2 |
1.000
|
|
|
|
menstruation
|
GO:0042703 |
1 |
1.000
|
|
|
|
hard palate development
|
GO:0060022 |
1 |
1.000
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
3 |
1.000
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.999
|
|
|
|
enteric nervous system development
|
GO:0048484 |
1 |
0.999
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.996
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.990
|
Mouse |
|
|
soft palate development
|
GO:0060023 |
3 |
0.981
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
3 |
0.981
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
2 |
0.974
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.973
|
|
|
|
blastocyst formation
|
GO:0001825 |
3 |
0.964
|
Mouse |
|
|
tongue development
|
GO:0043586 |
1 |
0.962
|
|
|
|
nucleosome assembly
|
GO:0006334 |
50 |
0.960
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.941
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
4 |
0.938
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.934
|
|
|
|
lymphangiogenesis
|
GO:0001946 |
7 |
0.932
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.929
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.926
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.920
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.918
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.915
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.911
|
Mouse |
|
|
equilibrioception
|
GO:0050957 |
6 |
0.906
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.897
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.889
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.884
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.874
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.868
|
|
|
|
neural crest cell migration
|
GO:0001755 |
2 |
0.860
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.852
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.847
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.844
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.837
|
|
|
|
positive regulation of male gonad development
|
GO:2000020 |
3 |
0.827
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.817
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.815
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.814
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.809
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.803
|
|
|
|
negative regulation of epithelial to mesenchymal transition
|
GO:0010719 |
14 |
0.797
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.796
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.793
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.789
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.784
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
22 |
0.773
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.765
|
Mouse |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.765
|
|
|
|
pancreas development
|
GO:0031016 |
19 |
0.760
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.752
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.748
|
|
|
|
male genitalia development
|
GO:0030539 |
1 |
0.745
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.744
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.739
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.734
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.712
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.706
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.702
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.702
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.700
|
|
|
|
detection of mechanical stimulus involved in sensory perception
|
GO:0050974 |
1 |
0.690
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.687
|
Human |
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.683
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
2 |
0.682
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.678
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
1 |
0.667
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.665
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.660
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.656
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.638
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.638
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.638
|
|
|
|
lymph vessel development
|
GO:0001945 |
9 |
0.628
|
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.622
|
|
|
|
cardiac cell fate commitment
|
GO:0060911 |
7 |
0.619
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.612
|
|
|
|
thyroid gland development
|
GO:0030878 |
5 |
0.609
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.598
|
Mouse |
|
|
stem cell development
|
GO:0048864 |
69 |
0.595
|
|
|
|
positive regulation of mesenchymal stem cell differentiation
|
GO:2000741 |
4 |
0.586
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.573
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.569
|
Mouse |
|
|
cell development
|
GO:0048468 |
328 |
0.569
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.551
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.549
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.546
|
|
|
|
female gonad development
|
GO:0008585 |
10 |
0.540
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.527
|
|
|
|
bone morphogenesis
|
GO:0060349 |
10 |
0.522
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.520
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.511
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.511
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.504
|
|
|
|
endoderm formation
|
GO:0001706 |
33 |
0.502
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.498
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.497
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.496
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.495
|
|
|
|
regulation of intracellular estrogen receptor signaling pathway
|
GO:0033146 |
13 |
0.494
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.492
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.490
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.490
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.489
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.488
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.487
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.473
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.470
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.468
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.468
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.456
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.444
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.442
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.441
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.441
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.438
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
42 |
0.433
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
55 |
0.433
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.429
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.425
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.417
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.412
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.412
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.411
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.410
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.404
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.395
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.391
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.388
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
23 |
0.386
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.385
|
|
|
|
lymph vessel morphogenesis
|
GO:0036303 |
7 |
0.376
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.373
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.370
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.368
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.361
|
|
|
|
brain morphogenesis
|
GO:0048854 |
1 |
0.361
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
4 |
0.355
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
6 |
0.351
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.346
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.346
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.344
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.343
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.342
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.337
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
48 |
0.334
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.330
|
|
|
|
gliogenesis
|
GO:0042063 |
21 |
0.329
|
|
|
|
negative regulation of sodium ion transmembrane transporter activity
|
GO:2000650 |
2 |
0.329
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.327
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.327
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
2 |
0.325
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.325
|
|
|
|
bone development
|
GO:0060348 |
26 |
0.319
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.318
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.317
|
|
|
|
endoderm development
|
GO:0007492 |
33 |
0.316
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.315
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.315
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.312
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.311
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.310
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.306
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.305
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.305
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.300
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.300
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.295
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.290
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.290
|
|
|
|
glial cell development
|
GO:0021782 |
7 |
0.285
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.285
|
|
|
|
regulation of coagulation
|
GO:0050818 |
44 |
0.282
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.281
|
|
|
|
nucleosome organization
|
GO:0034728 |
66 |
0.280
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.279
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.279
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.278
|
|
|
|
apoptotic nuclear changes
|
GO:0030262 |
13 |
0.272
|
|
|
|
ovulation cycle process
|
GO:0022602 |
9 |
0.272
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.272
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.270
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
42 |
0.269
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.261
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
3 |
0.258
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.254
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
5 |
0.250
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
11 |
0.250
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.249
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.249
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.246
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.243
|
|
|
|
ectodermal placode formation
|
GO:0060788 |
1 |
0.241
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.240
|
|
|
|
ovulation cycle
|
GO:0042698 |
9 |
0.236
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.233
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.231
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
37 |
0.227
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.222
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.219
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.218
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.216
|
|
|
|
regulation of wound healing
|
GO:0061041 |
56 |
0.216
|
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
5 |
0.213
|
|
|
|
dna catabolic process
|
GO:0006308 |
49 |
0.213
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.213
|
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.213
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.211
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
10 |
0.205
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.204
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.204
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.203
|
|
|
|
lung morphogenesis
|
GO:0060425 |
6 |
0.203
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.203
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.203
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.199
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.198
|
|
|
|
n terminal peptidyl lysine acetylation
|
GO:0018076 |
4 |
0.198
|
|
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.196
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
94 |
0.196
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.195
|
|
|
|
positive regulation of chondrocyte differentiation
|
GO:0032332 |
4 |
0.195
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.194
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.193
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.190
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.188
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.188
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.187
|
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
9 |
0.186
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.185
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.183
|
|
|
|
developmental pigmentation
|
GO:0048066 |
12 |
0.181
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.181
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.180
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.175
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.175
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.174
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.174
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.174
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
43 |
0.174
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.172
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.171
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
15 |
0.169
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.169
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
42 |
0.168
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.167
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.166
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.166
|
|
|
|
positive regulation of n terminal peptidyl lysine acetylation
|
GO:2000761 |
1 |
0.166
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
14 |
0.165
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.163
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.163
|
Human |
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.161
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
24 |
0.160
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.159
|
|
|
|
ovarian follicle development
|
GO:0001541 |
5 |
0.159
|
|
|
|
dna damage response detection of dna damage
|
GO:0042769 |
3 |
0.158
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.158
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.156
|
|
|
|
pigmentation
|
GO:0043473 |
22 |
0.156
|
|
|
|
palate development
|
GO:0060021 |
13 |
0.156
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.153
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.151
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
24 |
0.150
|
|
|
|
negative regulation of leukocyte activation
|
GO:0002695 |
26 |
0.148
|
|
|
|
execution phase of apoptosis
|
GO:0097194 |
32 |
0.147
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.146
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.145
|
|
|
|
chondrocyte differentiation involved in endochondral bone morphogenesis
|
GO:0003413 |
1 |
0.143
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.143
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.143
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
6 |
0.142
|
Mouse |
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.141
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.141
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
2 |
0.140
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.139
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
9 |
0.139
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.138
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.137
|
|
|
|
regulation of translation
|
GO:0006417 |
89 |
0.137
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.136
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.135
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.132
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.130
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.129
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.126
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.123
|
|
|
|
skeletal muscle tissue development
|
GO:0007519 |
24 |
0.121
|
|
|
|
stem cell maintenance
|
GO:0019827 |
19 |
0.120
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.120
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.119
|
|
|
|
cellular response to peptide
|
GO:1901653 |
59 |
0.118
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
76 |
0.115
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.114
|
|
|
|
endothelial cell development
|
GO:0001885 |
18 |
0.114
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.114
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.113
|
Human |
|
|
male gonad development
|
GO:0008584 |
23 |
0.113
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.112
|
Human |
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.112
|
|
|
|
hair cycle process
|
GO:0022405 |
12 |
0.111
|
|
|
|
cerebral cortex development
|
GO:0021987 |
10 |
0.111
|
|
|
|
ectodermal placode development
|
GO:0071696 |
1 |
0.110
|
|
|
|
mitotic g1 s transition checkpoint
|
GO:0044819 |
17 |
0.110
|
|
|
|
cell fate specification
|
GO:0001708 |
8 |
0.109
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.109
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.109
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.108
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.105
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.104
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.103
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.103
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.101
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.101
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.101
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.099
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.099
|
|
|
|
regulation of endosome size
|
GO:0051036 |
3 |
0.098
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
41 |
0.098
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.098
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
7 |
0.097
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.096
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.096
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.095
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.094
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.094
|
Human |
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.092
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.090
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.089
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
23 |
0.089
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.088
|
|
|
|
glial cell differentiation
|
GO:0010001 |
11 |
0.087
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.087
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.086
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.086
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.086
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.086
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.085
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
13 |
0.084
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
46 |
0.084
|
|
|
|
regulation of n terminal peptidyl lysine acetylation
|
GO:2000759 |
1 |
0.083
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.083
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.082
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.082
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.082
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.082
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.081
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.081
|
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
1 |
0.081
|
|
|
|
dolichol biosynthetic process
|
GO:0019408 |
1 |
0.081
|
|
|
|
sodium ion transport
|
GO:0006814 |
61 |
0.081
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.081
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.081
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.080
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
5 |
0.080
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
5 |
0.080
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
21 |
0.080
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
10 |
0.079
|
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
35 |
0.078
|
|
|
|
apoptotic dna fragmentation
|
GO:0006309 |
6 |
0.078
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
23 |
0.078
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.078
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.078
|
|
|
|
cellular component disassembly involved in execution phase of apoptosis
|
GO:0006921 |
13 |
0.077
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.076
|
Human |
|
|
regulation of isoprenoid metabolic process
|
GO:0019747 |
1 |
0.076
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.075
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.075
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.074
|
Mouse |
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.073
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.072
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.072
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.072
|
|
|
|
trna processing
|
GO:0008033 |
23 |
0.070
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.070
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
25 |
0.070
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
6 |
0.070
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.069
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.068
|
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
46 |
0.068
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.068
|
|
|
|
positive regulation of translation
|
GO:0045727 |
35 |
0.068
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.067
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.067
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.067
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.066
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
10 |
0.066
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.065
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.065
|
Human |
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
9 |
0.064
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
37 |
0.064
|
|
|
|
odontogenesis
|
GO:0042476 |
25 |
0.064
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.063
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.062
|
Human |
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
16 |
0.062
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
11 |
0.062
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
13 |
0.061
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
26 |
0.060
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
59 |
0.060
|
|
|
|
biological phase
|
GO:0044848 |
5 |
0.060
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.060
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.060
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.060
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.059
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.059
|
Human |
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.059
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.059
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.059
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.059
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.058
|
|
|
|
protein autoubiquitination
|
GO:0051865 |
37 |
0.058
|
|
|
|
response to insulin
|
GO:0032868 |
45 |
0.057
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.057
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.057
|
|
|
|
response to interleukin 1
|
GO:0070555 |
47 |
0.057
|
|
|
|
molting cycle process
|
GO:0022404 |
12 |
0.057
|
|
|
|
female sex differentiation
|
GO:0046660 |
12 |
0.056
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.056
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.056
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.055
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.055
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.055
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
26 |
0.053
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.053
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.053
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.052
|
Mouse |
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.052
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.052
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.052
|
|
|
|
dna packaging
|
GO:0006323 |
77 |
0.052
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.052
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.051
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
87 |
0.050
|
|
|
|
receptor internalization
|
GO:0031623 |
43 |
0.050
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.049
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.049
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.048
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.048
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.048
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.048
|
|
|
|
gonad development
|
GO:0008406 |
34 |
0.048
|
|
|
|
cartilage development
|
GO:0051216 |
31 |
0.047
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.047
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.047
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.047
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
2 |
0.047
|
|
|
|
mesenchymal stem cell differentiation
|
GO:0072497 |
8 |
0.047
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.046
|
|
|
|
negative regulation of nucleocytoplasmic transport
|
GO:0046823 |
37 |
0.046
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.046
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
10 |
0.045
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.045
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.045
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.045
|
|
|
|
developmental induction
|
GO:0031128 |
5 |
0.045
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.045
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.045
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.044
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.044
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.044
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.044
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.044
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.043
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.043
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.043
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.043
|
|
|
|
ear morphogenesis
|
GO:0042471 |
7 |
0.042
|
|
|
|
growth
|
GO:0040007 |
202 |
0.042
|
Mouse |
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
10 |
0.042
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.042
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.042
|
|
|
|
chromatin remodeling
|
GO:0006338 |
55 |
0.042
|
|
|
|
nuclear export
|
GO:0051168 |
69 |
0.042
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.041
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.041
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.041
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.040
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.040
|
Mouse |
|
|
hair cycle
|
GO:0042633 |
28 |
0.040
|
|
|
|
nephron development
|
GO:0072006 |
30 |
0.040
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.039
|
|
|
|
regulation of protein export from nucleus
|
GO:0046825 |
15 |
0.039
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.039
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.039
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.039
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
16 |
0.039
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.039
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.039
|
Human |
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.039
|
|
|
|
endosome transport via multivesicular body sorting pathway
|
GO:0032509 |
3 |
0.038
|
|
